| AEPCX | FIDZX | AEPCX / FIDZX | |
| Total Expense Ratio | 1.57 | 0.75 | 209% |
| Annual Report Gross Expense Ratio | 1.57 | 0.75 | 209% |
| Fund Existence | 25 years | 9 years | - |
| Gain YTD | 20.244 | 15.134 | 134% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 134B | 15.7B | 854% |
| Annual Yield % from dividends | 0.15 | 0.73 | 21% |
| Returns for 1 year | 11.33 | 10.84 | 105% |
| Returns for 3 years | 27.09 | 49.02 | 55% |
| Returns for 5 years | -1.08 | 32.07 | -3% |
| Returns for 10 years | 36.52 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| OARK | 37.87 | 30.41 | +407.64% |
| YieldMax ARKK Option Income Strategy ETF | |||
| IBHI | 23.61 | 0.06 | +0.28% |
| iShares iBonds 2029 Term HY & Inc ETF | |||
| OCTP | 30.13 | 0.06 | +0.20% |
| PGIM S&P 500 Buffer 12 ETF - Oct | |||
| EEMA | 93.07 | 0.18 | +0.19% |
| iShares MSCI Emerging Markets Asia ETF | |||
| WDNA | 16.92 | -0.08 | -0.48% |
| WisdomTree BioRevolution ETF | |||